Soliton, Inc. (SOLY) |
22.58 0 (0%) 12-31 19:00 |
Open: | 22.56 |
High: | 22.59 |
Low: | 22.56 |
Volume: | 1,347,169 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | NASDAQ Capital Market |
Industry: | Medical - Devices |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 26.39 |
Resistance 1: | 22.59 |
Pivot price: | 22.58 |
Support 1: | 22.57 |
Support 2: | 22.56 |
52w High: | 22.6 |
52w Low: | 7.53 |
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
EPS | -23210000.000 |
Book Value | 0.000 |
PEG Ratio | -0.51 |
Gross Profit | 0.000 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | -6.00 |
Return on Assets (ttm) | 421.4 |
Return on Equity (ttm) | -47.6 |
Thu, 16 Dec 2021
Allergan Aesthetics Completes Acquisition of Soliton - PR Newswire
Mon, 10 May 2021
Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio - PR Newswire
Wed, 05 May 2021
Introducing RESONICâ„¢ - PR Newswire
Sun, 21 Feb 2021
Soliton: Slow, Steady Progress Could Win Tattoo & Cellulite Removal Race (NASDAQ:SOLY) - Seeking Alpha
Thu, 22 Oct 2020
Soliton Appoints Niquette Hunt to Board of Directors - BioSpace
Thu, 13 Aug 2020
Soliton Introduces Advanced Design for RAP Cartridges - BioSpace
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |